Ab asli scenario kya hai, woh samajhte hain.
Prism Medico And Pharmacy Limited ne apne Q3 FY26 ke results nikale hain aur numbers dekh kar lag raha hai ki kuch toh gadbad hai.
Revenue Ka Scene:
Sabse pehle toh, company ka 'revenue from operations' saal-dar-saal (YoY) 85.86% gir gaya hai. Last year is quarter mein yeh ₹50.23 Cr tha, jo ab sudhar kar sirf ₹7.10 Cr pe aa gaya hai. Pichle quarter se compare karein toh bhi 65.96% ka girawat dikh raha hai, jo ₹20.86 Cr se kam hokar ₹7.10 Cr ho gaya.
Accounting Mein Badi Gadbad (The Anomaly):
Lekin asal chinta ki baat yeh hai ki company ne 'Total income from operations' ₹71.79 Cr report kiya hai. Jabki agar 'Revenue from operations' (₹7.10 Cr) aur 'Other income' (₹0.69 Cr) ko milayein, toh total sirf ₹7.79 Cr banta hai. Ye ₹71.79 Cr aur ₹7.79 Cr ka difference ek dum se bahar aaya hai aur yeh ek badi accounting anomaly hai, jisne financial reporting ki sachchai par sawaal khada kar diya hai.
Loss Aur Profit Ka Khel:
Quarterly basis pe, company ko ₹1.34 Cr ka Net Loss hua hai. Yeh last year ke ₹8.48 Cr ke loss se toh behtar hai, par pichle quarter ke ₹0.96 Cr ke loss se thoda zyada hai. Dilute EPS bhi ₹(0.0002) tha.
Par haan, 9 mahine ki performance dekhein toh company ne ₹55.91 Cr ka Net Profit kamaya hai, jo last year ke ₹4.87 Cr ke loss se kaafi achha turnaround hai.
Ab market aur investors ke mann mein do bade sawaal hain:
- 'Revenue from operations' itna 85.86% YoY kaise gir gaya?
- Aur sabse important, 'Total income from operations' (₹71.79 Cr) aur uske components ka total (₹7.79 Cr) ke beech ka ₹64 Cr ka gap kya hai? Yeh inconsistency bahut badi hai aur company ko iska poora, clear explanation dena hoga taaki investors ka trust wapas aa sake.